Back to mobile site

More on MDCX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/20/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Medicus Pharma (NQ:MDCX)
Delayed: 0.34 +0.01 (3.03%)
Prev. Close $0.33  
Open$0.33 
52 Wk High$ 
52 Wk Low$ 
Day High$0.34 
Day Low$0.32 
P/E N/A  
EPS$ 
Volume955,991 

Friends, Peers and Foes (?): MDPLF, YYGH, VTIX, NRXP, SNYR (more...)

Jun 12, 2026 02:45 PM New to The Street Broadcasting Saturday June 13th 630pm est ACROSS BLOOMBERG TELEVISION IN THE U.S., LATIN AMERICA, AND MENA
Jun 11, 2026 07:30 AM Medicus Pharma starts genomic endometriosis trial in UAE
Jun 11, 2026 07:30 AM Medicus Pharma Initiates Groundbreaking PRECISION-E2 Phase 2a Study of Teverelix® in Endometriosis utilizing the Emirati Genome Program
Jun 8, 2026 07:32 AM Medicus Pharma submits European filing for Teverelix prostate cancer study
Jun 8, 2026 07:30 AM Medicus Pharma Advances Teverelix® Program Towards Registrational Development Targeting High Cardiovascular-Risk Prostate Cancer Patients with Key European Submission
Jun 6, 2026 11:20 AM New to The Street Broadcasts Tonight on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM ET
Jun 4, 2026 05:04 PM Form 424B3 Medicus Pharma Ltd.
Jun 4, 2026 04:31 PM Form 8-K Medicus Pharma Ltd. For: Jun 03
Jun 4, 2026 04:20 PM Form 4 Medicus Pharma Ltd. For: Jun 03 Filed by: Smith Andrew Alasdair
Jun 4, 2026 04:18 PM Form 4 Medicus Pharma Ltd. For: Jun 03 Filed by: Rodgers Cathy McMorris
View All Articles

Entities mentioned with MDCX

View All Entities